UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020004
Receipt number R000023077
Scientific Title Evaluation of Conditioned Pain Modulation with a quantitative thermal stimulator device
Date of disclosure of the study information 2015/11/30
Last modified on 2017/06/01 13:21:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of Conditioned Pain Modulation with a quantitative thermal stimulator device

Acronym

Evaluation of Conditioned Pain Modulation with a quantitative thermal stimulator device

Scientific Title

Evaluation of Conditioned Pain Modulation with a quantitative thermal stimulator device

Scientific Title:Acronym

Evaluation of Conditioned Pain Modulation with a quantitative thermal stimulator device

Region

Japan


Condition

Condition

healthy adult volunteers

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

For the objective evaluation of Conditioned Pain Modulation (CPM), test stimulus (TS) and conditioning stimulus (CS) should be quantified. We have developed a new pressure algometer to measure quantitative pressure pain threshold (PPT) and have reported that the new algometer is useful to use as TS to evaluate CPM. We have also developed a quantitative thermal stimulator device (QTSD) to deliver quantitative thermal stimulus. The QTSD is designed as it is possible to switch the temperature (heat and cold). The aim of the study is to investigate whether QTSD is useful as CS to evaluate CPM or other sensation.

Basic objectives2

Others

Basic objectives -Others

For the objective evaluation of Conditioned Pain Modulation (CPM), test stimulus (TS) and conditioning stimulus (CS) should be quantified. We have developed a new pressure algometer to measure quantitative pressure pain threshold (PPT) and have reported that the new algometer is useful to use as TS to evaluate CPM. We have also developed a quantitative thermal stimulator device (QTSD) to deliver quantitative thermal stimulus. The QTSD is designed as it is possible to switch the temperature (heat and cold). The aim of the study is to investigate whether QTSD is useful as CS to evaluate CPM or other sensation.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

CPM effect
Evaluation of CPM effect is assessed by Quantitative Sensory Testing (QST) such as Pressure Pain threshold measured by pressure algometer or threshold measured by von Frey filament as subjective evaluation and objective evaluation by Visual Analogue Scale (VAS) etc. The CPM effect is evaluated during and after conditioning stimulation. CPM effect is defined as ratio of pain threshold of TS during CS to pain threshold before application of CS (baseline).

Key secondary outcomes

modulation of sensation by QTSD


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

Tonic CS is applied to the forearm by QTSD with a pain intensity of 70 on VAS (0-100) for about 6 minutes. For CPM evaluation, PPT is measured at contralateral forearm before, during, and after CS.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy adult volunteers after informed consent is obtained

Key exclusion criteria

(1) a medical condition such as neurological, psychiatric diseases; (2) the inability to give informed consent; and (3) the current use of analgesic drugs, anti-depressants, or cough suppressants.

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hikaru Kohase

Organization

Department of Diagnostic and Therapeutic Sciences, School of Dentistry, Meikai University

Division name

Division of Dental Anesthesiology

Zip code


Address

1-1, Keyakidai, Sakado-shi, Saitama

TEL

049-279-2738

Email

hkohase@dent.meikai.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hikaru Kohase

Organization

Department of Diagnostic and Therapeutic Sciences, School of Dentistry, Meikai University

Division name

Division of Dental Anesthesiology

Zip code


Address

1-1, Keyakidai, Sakado-shi, Saitama

TEL

049-279-2738

Homepage URL


Email

hkohase@dent.meikai.ac.jp


Sponsor or person

Institute

Division of Dental Anesthesiology, Department of Diagnostic and Therapeutic Sciences, School of Dentistry, Meikai University

Institute

Department

Personal name



Funding Source

Organization

Japan Society for the Promotion of Science

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

Center for Sensory-Motor Interaction (SMI), Aalborg University

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 11 Month 30 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 07 Month 31 Day

Date of IRB


Anticipated trial start date

2015 Year 11 Month 30 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 11 Month 30 Day

Last modified on

2017 Year 06 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023077


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name